Finally Doing Its Job: FDA Places Hold on All Clinical Studies of RSV Vaccines in Infants
Updated
If only this had happened with the deadly mRNA COVID-19 jabs, which triggered thousands upon thousands of severe adverse events. What, you ask? The pause of a trial due to severe adverse events, of course. Enrollment in a Phase 1 trial by Moderna that was evaluating the safety and efficacy of two mRNA-based RSV vaccine…Continue reading Finally Doing Its Job: FDA Places Hold on All Clinical Studies of RSV Vaccines in Infants